(LAZ) Lazard - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: BMG540501027
LAZ: Mergers, Acquisitions, Restructuring, Investment Management
Lazard Ltd (NYSE:LAZ) is a global financial advisory and asset management firm with operations spanning the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company is divided into two primary segments: Financial Advisory and Asset Management. The Financial Advisory segment provides a comprehensive suite of services, including mergers and acquisitions, capital markets advisory, shareholder and sovereign advisory, restructuring, liability management, and capital raising. This segment caters to a diverse client base, including corporations, governments, sovereign entities, and institutional investors, across industries such as consumer and retail, financial institutions, healthcare and life sciences, industrials, media, entertainment, sports, power, energy, infrastructure, real estate, technology, and telecom and digital infrastructure. The Asset Management segment offers tailored investment solutions, including equity and fixed income strategies, asset allocation, and alternative investments such as private equity funds. It serves a broad range of clients, including public funds, sovereign entities, endowments, foundations, labor funds, financial intermediaries, and private clients. Lazard Ltd, founded in 1848, is headquartered in New York, New York.
From a financial perspective, Lazard Ltd (NYSE:LAZ) currently trades at $38.64 with a market capitalization of $3.584 billion. The stock exhibits a trailing P/E of 14.88 and a forward P/E of 15.17, reflecting moderate valuation relative to earnings. The price-to-book ratio stands at 5.36, indicating a premium to book value. The price-to-sales ratio is 1.18, suggesting reasonable revenue multiples. The return on equity (RoE) is 50.50%, highlighting strong profitability. Technically, the stock has averaged 1.44 million shares traded over the past 20 days, with a last price of $38.64. Key moving averages include SMA 20 at $37.71, SMA 50 at $44.04, and SMA 200 at $48.47. The Average True Range (ATR) is $2.53, indicating moderate volatility.
Additional Sources for LAZ Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
LAZ Stock Overview
Market Cap in USD | 3,632m |
Sector | Financial Services |
Industry | Capital Markets |
GiC Sub-Industry | Investment Banking & Brokerage |
IPO / Inception | 2005-05-05 |
LAZ Stock Ratings
Growth Rating | 48.2 |
Fundamental | 13.3 |
Dividend Rating | 79.2 |
Rel. Strength | -14.1 |
Analysts | 3.56/5 |
Fair Price Momentum | 35.99 USD |
Fair Price DCF | 123.87 USD |
LAZ Dividends
Dividend Yield 12m | 5.79% |
Yield on Cost 5y | 12.91% |
Annual Growth 5y | 1.25% |
Payout Consistency | 96.4% |
LAZ Growth Ratios
Growth Correlation 3m | -91.9% |
Growth Correlation 12m | 35% |
Growth Correlation 5y | 48.2% |
CAGR 5y | 14.97% |
CAGR/Max DD 5y | 0.34 |
Sharpe Ratio 12m | -0.43 |
Alpha | -10.22 |
Beta | 1.486 |
Volatility | 73.63% |
Current Volume | 782.8k |
Average Volume 20d | 1440.4k |
As of May 01, 2025, the stock is trading at USD 38.90 with a total of 782,843 shares traded.
Over the past week, the price has changed by +2.56%, over one month by -10.16%, over three months by -27.77% and over the past year by +5.39%.
Neither. Based on ValueRay Fundamental Analyses, Lazard is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 13.34 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LAZ as of May 2025 is 35.99. This means that LAZ is currently overvalued and has a potential downside of -7.48%.
Lazard has received a consensus analysts rating of 3.56. Therefor, it is recommend to hold LAZ.
- Strong Buy: 2
- Buy: 2
- Hold: 4
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, LAZ Lazard will be worth about 40.1 in May 2026. The stock is currently trading at 38.90. This means that the stock has a potential upside of +3.03%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 41.6 | 6.9% |
Analysts Target Price | 58.4 | 50.2% |
ValueRay Target Price | 40.1 | 3% |